Exponent, Inc. (NASDAQ: EXPO) reported Q3 EPS of $0.50, $0.02 better than the analyst estimate of $0.48. Revenue for the quarter came in at $136.3 million versus the consensus estimate of $125.66 million.

Business Outlook
“Our ability to align our operating model with market demand resulted in 75% utilization and expanded profitability in the first nine months of 2024. We are encouraged by the market opportunities across the industries that we serve, and our recruiting activity is increasing as we strategically build upon our diversified portfolio of talent and capabilities,” commented Richard Schlenker, Executive Vice President and Chief Financial Officer. “As we close out 2024, we are maintaining our revenue guidance and raising our margin guidance for the full-year.”

For the fourth quarter of 2024, which includes the impact of an additional week, as compared to the same period one year prior, Exponent anticipates:

Revenues before reimbursements to grow in the mid-single digits; and,
EBITDA1 to be 23.5% to 24.5% of revenues before reimbursements.

For the fiscal year 2024, which includes the impact of an additional week, as compared to the same period one year prior, Exponent anticipates:

Revenues before reimbursements to grow in the low to mid-single digits; and,
EBITDA1 to be 27.9% to 28.1% of revenues before reimbursements

For earnings history and earnings-related data on Exponent, Inc. (EXPO) click here.